Transcription of GUIDELINES ON VALIDATION APPENDIX 4 …
{{id}} {{{paragraph}}}
Working document June 2016 Draft document for comment 1 GUIDELINES ON VALIDATION APPENDIX 4 2 analytical METHOD VALIDATION 3 (June 2016) 4 DRAFT FOR COMMENTS 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 World Health Organization 2016 25 All rights reserved. 26 This draft is intended for a restricted audience only, the individuals and organizations having received this draft. The draft 27 may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any 28 form or by any means outside these individuals and organizations (including the organizations' concerned staff and member 29 organizations) without the permission of the World Health Organization.
Working document QAS/16.671 June 2016 Draft document for comment 1 2 GUIDELINES ON VALIDATION – APPENDIX 4 3 ANALYTICAL METHOD VALIDATION (June4 2016) 5 DRAFT FOR COMMENTS
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Chapter-2 Analytical Method Development and, Chapter-2 Analytical Method Development and Validation, Development, Description & Person Profile Senior Analytical, Description & Person Profile Senior Analytical Development Scientist, Analytical Development, Sitagliptin Phosphate: Development of a, Sitagliptin Phosphate: Development of a Dissolution Method, Analytical method, Analytical Method Selection for Drug Product, Analytical Method Selection for Drug Product Dissolution, BROMINE 6011 See CHLORINE, Method 6011, for, BROMINE 6011 See CHLORINE, Method 6011, for procedure, METHOD